| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.12. | Atlantic Sapphire ASA: Grant of Share Options - Primary Insider Notification | ||
| 24.10. | Disclosure of significant shareholding in Atlantic Sapphire ASA | ||
| 18.10. | Atlantic Sapphire ASA: Mandatory notification of trades | ||
| 18.10. | Atlantic Sapphire ASA: Information about the warrants to be listed | ||
| 17.10. | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.10.2024 | Das Instrument 4SM NO0010187032 MAGNORA ASA NK 0,50 EQUITY wird cum Kapitalmassnahme gehandelt am 17.10.2024 und ex Kapitalmassnahme am 18.10.2024 The instrument 4SM NO0010187032 MAGNORA ASA NK 0,50... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.12. | BerGenBio ASA: Financial calendar | ||
| 26.11. | BERGENBIO ASA: BerGenBio to Present Company Update at DNB Nordic Healthcare Conference | ||
| 21.11. | BerGenBio Names New CEO | ||
| 20.11. | BerGenBio ASA: BerGenBio Appoints Olav Hellebø as CEO | BERGEN, Norway, Nov. 20, 2024 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical... ► Artikel lesen | |
| 13.11. | BerGenBio ASA: BerGenBio Third Quarter Results 2024 | BERGEN, Norway, Nov. 13, 2024 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharma-ceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.12. | BioCardia-Aktie fällt auf 52-Wochen-Tief von 1,81 US-Dollar | ||
| 19.12. | BioCardia stock plunges to 52-week low of $1.81 amid market challenges | ||
| 17.12. | BioCardia, Inc.: BioCardia Announces Commercial Availability of Morph DNA Steerable Introducer Product Family | SUNNYVALE, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases... ► Artikel lesen | |
| 17.12. | BioCardia, Inc. - 8-K, Current Report | ||
| 04.12. | BioCardia nears Japan registration for heart failure therapy |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.11. | Spotlight Stock Market: Market Notice 232/24- Last day of trading in WntResearch AB's subscription option WNT TO 7 | ||
| 17.10. | WntResearch updates after stopped study | ||
| 09.10. | Spotlight Stock Market: Market notice 196/24 - WntResearch AB's share WNT is moved to the Observation List | ||
| 09.10. | WntResearch provides an update on the work in progress to safeguard the interests of shareholders and company values | ||
| 20.09. | WntResearch plummets after results |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| ATLANTIC SAPPHIRE ASA | 0,017 | +142,86 % |
| BERGENBIO ASA | 0,738 | -2,89 % |
| BIOCARDIA INC | 2,100 | +6,60 % |
| WNTRESEARCH AB | 1,075 | 0,00 % |
